Insight journal - Company

Big pharma Eli Lilly M&A deals for 2005-2013

Posted on 05 March 2013

Tags: , ,

Eli Lilly has announced over 8 M&A deals since 2005, with the lead deals being the acquisition of Imclone Systems and Icos.

Abstracted from: Partnering Deals and Alliances with Eli Lilly

Eli Lilly seems to cycle through a period off active acquisition followed by periods of inactivity. This is probably due to the need to assimilate acquisitions into the corporate structure and adjust strategy as a consequence of such assimilation. Periods of inactivity normally follow a major acquisition as was the case after acquisition of Icos and Imclone Systems.

The following figure shows the level of Eli Lilly's M&A deals announcements since 2005.

Figure 1: Eli Lilly M&A deals 2005-2012

Eli Lilly M&A deals by year

Source: Current Agreements, 2013

Eli Lilly has signed 9 M&A deals since 2005. Companies acquired include:

  • Chemgen
  • Avid Radiopharmaceuticals
  • Alnara Pharmaceuticals
  • Imclone Systems
  • SGX Pharmaceutcials
  • Hypnion
  • Icos

View the full list at Current Agreements (subscription required)

Eli Lilly has been partially attracted to mega merger transactions whereby the company expands through the acquisition and assimilation of strategic target assets to realize business growth. This is evidenced by the acquisitions of Icos and Imclone Systems, the latter to get a strategic position in the biotech sector.

The following figure provides a summary of the top m&a deals by headline value.

Figure 2: Top Eli Lilly M&A deals by headline value 2005-2013

Eli Lilly M&A deals by headline value

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Eli Lilly

 

Eli Lilly M&A at Current Agreements       

View all M&A deals for Eli Lilly: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Eli Lilly

 

More

Summary profile data for Eli Lilly

Partnering interests for Eli Lilly

Partnering activity for Eli Lilly

 

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Eli Lilly

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Eli Lilly

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Eli Lilly company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

Report: Partnering Deals and Alliances with Big Pharma                 

Report: Partnering Deals and Alliances with Eli Lilly

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new2gif
rauconbadgejpg
e78banner300x150animgif
cabannerad300x150new4gif
e79banner300x150gif
amsbanner300x150jpg